NUZ vs PHX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

NUZ

NEURITHERA FPO [NUZ]

41LOW

PHX

PHARMX FPO [PHX]

42LOW

Score Breakdown

NUZ PHX
Technical
48
57
Catalyst
53
51
Sentiment
50
50
Fundamental
43
66
Momentum
36
55
Risk Gate
50
50

Key Metrics

NUZ Metric PHX
$51.2MMarket Cap$79.1M
1.1MAvg Volume (20d)448K
N/AShort InterestN/A
$0.18552-Week High$0.200
$0.05552-Week Low$0.084
-3.0%Daily Change+0.0%
$0.065Reference Price$0.120
-147.1%ROE-5.9%
-248.4%Profit Margin-12.2%

Active Signals

NUZ Signals

●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.8 quarters)
●Moderate P/S ratio (8.6x)
●Strong revenue growth (+290%)
●Near 52-week low (9% of range)
●Small-cap ($20-100M)
●Capital raise activity (1 events)
●Deeply negative margins (-248%)

PHX Signals

●Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (10.3x)
●Small-cap ($20-100M)
●Capital raise activity (1 events)
●CANSLIM S: Tight float (41%)
●Negative profit margins (-12%)

Ask Scout AI to compare NUZ and PHX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

NXN vs PAR →NXN vs SPL →NXN vs TTX →NXN vs VIT →NYR vs PIQ →
NUZ Full Analysis → PHX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).